Photodynamic therapy using Photofrin and excimer dye laser treatment for superficial oral squamous cell carcinomas with long-term follow up

Photodiagnosis and Photodynamic Therapy

Volumn 14, Issue , 2016, Pages 104-110

  Toratani, Shigeaki ^a   Tani, Ryouji ^b   Kanda, Taku ^b   Koizumi, Koichi ^a   Yoshioka, Yukio ^a   Okamoto, Tetsuji ^a,b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Excimer dye laser; Oral squamous cell carcinoma; Photodynamic therapy (PDT); Photofrin

Indexed keywords

ANALGESIC AGENT; LOCAL ANESTHETIC AGENT; NARCOTIC AGENT; PHOTOFRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CAUSE SPECIFIC SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; COLOR; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; EXCIMER LASER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; JAW DISEASE; MALE; MAXILLARY SINUS PERFORATION; MOUTH SQUAMOUS CELL CARCINOMA; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; NECK METASTASIS; ORAL SURGERY; OVERALL SURVIVAL; PAIN; PATIENT HISTORY OF THERAPY; PERFORATION; PHOTODYNAMIC THERAPY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; RECURRENCE RISK; RETROSPECTIVE STUDY; SUNBURN; SURGICAL WOUND; SWELLING; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR NECROSIS; VERY ELDERLY; WOUND HEALING; CARCINOMA, SQUAMOUS CELL; DYE LASER; MIDDLE AGED; MOUTH NEOPLASMS; PATHOLOGY; THERAPEUTIC USE; TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COLOR; DIHEMATOPORPHYRIN ETHER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASERS, DYE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHOTOSENSITIZING AGENTS; RETROSPECTIVE STUDIES; TIME; TREATMENT OUTCOME;

EID: 84962362100     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2015.12.009     Document Type: Article

References (32)

1. Kelly J.F., Snell M.E., Berenbaum M.C. Photodynamic destruction of human bladder carcinoma. Br. J. Cancer 1975, 31:237-244.
2. Dougherty T.J., Kaufman J.E., Goldfarb A., Weishaupt K.R., Boyle D., Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978, 38:2628-2635.
3. Pass H.I. Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 1993, 85:443-456.
4. Allison R.R., Moghissi K. Oncologic photodynamic therapy: clinical strategies that modulate mechanisms of action. Photodiagn. Photodyn. Ther. 2013, 10:331-341.
5. Hayata Y., Kato H., Konaka C., Amemiya R., Ono J., Ogawa I., et al. Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer. Chest 1984, 86:169-177.
6. Mimura S., Ito Y., Nagayo T., Ichii M., Kato H., Sakai H., et al. Cooperative clinical trial of photodynamic therapy with Photofrin II and excimer dye laser for early gastric cancer. Laser Surg. Med. 1996, 19:168-172.
7. Yano T., Muto M., Minashi K., Ohtsu A., Yoshida S. Photodynamic therapy as salvage treatment for local failures after chemoradiotherapy for esophageal cancer. Gastrointest. Endosc. 2005, 62:31-36.
8. Karrer S., Szeimies R.M. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am. J. Clin. Dermatol. 2001, 2:229-237.
9. Allison R.R., Cuenca R.E., Downie G.H., Camnitz P., Brodish B., Shibata C.H. Clinical photodynamic therapy of head and neck cancers-a review of applications and outcomes. Photodiagn. Photodyn. Ther. 2005, 2:205-222.
10. Schweitzer V.G., Somers M.L. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx. Lasers Surg. Med. 2010, 42:1-8.
11. Gluckman J.L. Hematoporphyrin photodynamic therapy: is there truly a future in head and neck oncology? Reflection on a 5-years experience. Laryngoscope 1991, 101:36-42.
12. Grant W.E., Hopper C., Speight P.M., Macrobert A.J., Bown S.G. Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity. J. Laryngol. Otol. 1993, 107:1140-1145.
13. Biel M.A. Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope 1998, 108:1259-1268.
14. Castano A.P., Demidova T.N., Hamblin M.R. Mechanisms in photodynamic therapy: part one -photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 2004, 1:279-293.
15. Castano A.P., Demidova T.N., Hamblin M.R. Mechanism in photodynamic therapy: part three -photosensitizer pharmacokinetics, biodistribution, tumor location and modes of tumor destruction. Photodiagn. Photodyn. Ther. 2005, 2:91-106.
16. Engbrecht B.W., Menon C., Kachur A.V., Hahn S.M., Fraker D.L. Photofrin-mediated photodynamic therapy induced vascular occlusion and apoptosis in a human sarcoma xenograft model. Cancer Res. 1999, 59:4334-4342.
17. Castano A.P., Mroz P., Hamblin M.R. Photodynamic therapy and anti-tumor immunity. Nat. Rev. Cancer 2006, 6:535-545.
18. Korbelik M., Dougherty G.J. Photodynamic therapy-mediated immune response against subcutaneous mouse tumor. Cancer Res. 1999, 59:1941-1946.
19. Gollnick S.O., Evans S.S., Baumann H., Owczarczak B., Maier P., Vaughan L., et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br. J. Cancer 2003, 88:1772-1779.
20. Korbelik M., Sun J., Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res. 2005, 65:1018-1026.
21. Sobin L.H., Wittekind C.H. International Union Against Cancer. TNM Classification of Malignant Tumors 2002, Wiley. 6th ed.
22. Grant W.E., Speight P.M., Hopper C., Bown S.G. Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity. Int. J. Cancer 1997, 71:937-942.
23. Hopper C., Kübler A., Lewis H., Tan I.B., Putnam G. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int. J. Cancer 2004, 111:138-146.
24. de Visscher S.A.H., Melchers L.J., Dijkstra P.U., Karakullukeu B., Tan I.B., Hopper C., Roodenburg J.N.L., Witjes M.J.H. mTHPC-mediated photodynamic therapy of early stage oral squamous cell carcinoma: a comparison to surgical treatment. Ann. Surg. Oncol. 2013, 20:3076-3082.
25. Luryi A.L., Chen M.M., Mehra S., Roman A.S., Sosa J.A., Judson B.L. Treatment factor associated with survival in early-stage oral cavity cancer. Analysis of 6830 cases from the National Cancer Date Base. JAMA Otolaryngol. Head Neck Surg. 2015, 141:593-598.
26. Umeda M., Komatubara H., Ojima Y., Minamikawa T., Shibuya Y., Yokoo S., Ishii J., Komori T. A comparison of brachytherapy and surgery for treatment of stage I-II squamous cell carcinoma of the tongue. Int. J. Oral Maxillofac. Surg. 2005, 34:739-744.
27. Slaughter D., Southwick W., Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications multicentric origin. Cancer 1953, 6:963-968.
28. Castano A.P., Demidova T.N., Hamblin M.R. Mechanisms in photodynamic therapy: part two -cellular signaling, cell metabolism and modes of cell death. Photodiagn. Photodyn. Ther. 2005, 2:1-23.
29. Morgan J., Oseroff A.R. Mitochondria-based photodynamic anti-cancer therapy. Adv. Drug Deliv. Rev. 2001, 49:71-86.
30. Hashibe M., Ritz B., Le A.D., Li G., Sankaranarayanan R., Zhang Z.-F. Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett. 2005, 220:185-195.
31. Takahashi H., Nakajima S., Sakata A., Ishida-Yamamoto A., Iizuka H. ATX-S10(Na)- photodynamic therapy is less carcinogenic for mouse skin compared with ultraviolet B irradiation. Br. J. Dermatol. 2005, 153:1182-1186.
32. Jerjes W., Upile T., Hamdoon Z., Mosse C.A., Akram S., Hopper C. Photodynamic therapy outcome for oral dysplasia. Lasers Surg. Med. 2011, 43:192-199.